Larvol Delta - VIRTUAL-Withdrawn-Efficacy-and-safety-of-the-IL6-transsignalling-inhibitor-olamkicept-a-phase-2-randomized-placebocontrolled-trial-in-moderately-to-severely-active-Ulcerative-Colitis

olamkicept (FE999301) - Ferring

https://www.ecco-ibd.eu/publications/congress-abstracts/item/dop01-has-been-withdrawn.html

Shenghong Zhang

May 5, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next